Logo image
Advances and gaps in SARS-CoV-2 infection models
Journal article   Open access   Peer reviewed

Advances and gaps in SARS-CoV-2 infection models

César Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, Martin Beer, Miles W Carroll, Emmie de Wit, Michael S Diamond, William E Dowling, Simon GP Funnell, Adolfo García-Sastre, …
PLoS pathogens, Vol.18(1), e1010161
01/13/2022
DOI: 10.1371/journal.ppat.1010161
PMCID: PMC8757994
PMID: 35025969
url
https://doi.org/10.1371/journal.ppat.1010161View
Published (Version of record) Open Access

Abstract

The global response to Coronavirus Disease 2019 (COVID-19) is now facing new challenges such as vaccine inequity and the emergence of SARS-CoV-2 variants of concern (VOCs). Preclinical models of disease, in particular animal models, are essential to investigate VOC pathogenesis, vaccine correlates of protection and postexposure therapies. Here, we provide an update from the World Health Organization (WHO) COVID-19 modeling expert group (WHO-COM) assembled by WHO, regarding advances in preclinical models. In particular, we discuss how animal model research is playing a key role to evaluate VOC virulence, transmission and immune escape, and how animal models are being refined to recapitulate COVID-19 demographic variables such as comorbidities and age. status: Published online

Details

Metrics

Logo image